Similar Articles
951 Biomarkers for the early diagnosis of hepatocellular carcinoma
952 Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma
953 Does herbal medicine reduce the risk of hepatocellular carcinoma?
954 Potentiality of immunotherapy against hepatocellular carcinoma
955 Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system
956 Predictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there?
957 Ursodeoxycholic acid induces apoptosis in hepatocellular carcinoma xenografts in mice
958 Liver resection for hepatocellular carcinoma using a microwave tissue coagulator: Experience of 1118 cases
959 Predictive value of quantitative contrast-enhanced ultrasound in hepatocellular carcinoma recurrence after ablation
960 Chemoembolization alone vs combined chemoembolization and hepatic arterial infusion chemotherapy in inoperable hepatocellular carcinoma patients
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA